Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

Inclusion Criteria

• •Patients over 18 years
• •Patients followed in a NeuroEndocrine Tumor center with a reference cardiologist
• •Patient with:
• •* Histologically documented metastatic well-differentiated ileum neuroendocrine tumor or
• •* Histologically documented metastatic well-differentiated bronchial neuroendocrine tumor, or
• •* Histologically documented well differentiated neuroendocrine tumor, regardless of the primitive site or unknown primitive site and presenting a carcinoid syndrome and / or an elevation of urinary 5HIAA \> 2 fold the upper limit of normal range
• •Information given to the patient and his documented non-opposition